COLL logo

Collegium Pharmaceutical (COLL)

Profile

Full Name

Collegium Pharmaceutical, Inc.

Ticker Symbol

COLL

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

May 7, 2015

Indexes

Not included

Website

http://www.collegiumpharma.com

Employees

357

Key Details

Price

$26.79(+0.04%)

Market cap

$843.50M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$631.45M(+11.41% YoY)

Annual EPS

$1.86(+44.19% YoY)

PE ratio

14.40

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$26.79
COLL price is $26.79

30-Day Relative Volume

0.46
COLL 30-day relative volume is 0.46

Price Performance

Price Most recent change

+0.04%
COLL price was up +0.04% on Apr 25, 2025

Price YTD change

-6.49%
COLL price is down -6.49% since January 1st

Price 1-year change

-25.25%
COLL price is down -25.25% year-on-year

Price 3-year change

+53.35%
COLL price is up +53.35% over the past 3 years

Price Range

Price All-time high

$42.29
COLL price is currently -36.65% below its historical high of $42.29

Price 3-year low

$14.04
COLL price is currently +90.81% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$843.50M
COLL market capitalization is $843.50 million

Market cap 3-year change

+42.33%
COLL market capitalization is up +42.33% over the past 3 years

Market cap All-time high

$1.36B
COLL market capitalization is currently -37.87% below its historical high of $1.36 billion

Market cap sector rank

73.99%
COLL market capitalization is higher than 73.99% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-3.73%
COLL shares outstanding is down -3.73% year-on-year

Shares Outstanding 3-Year Change

-7.19%
COLL shares outstanding is down -7.19% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.51
COLL beta is 0.51

200-day SMA

$32.64
COLL price is currently -17.93% below its 200-day simple moving average

50-day SMA

$28.63
COLL price is currently -6.43% below its 50-day simple moving average

RSI

43.79
COLL 14-day relative strength index is 43.79

Volume

0.46
COLL 30-day relative volume is 0.46

ATR

$1.20
COLL average true range is $1.20

10-day Historical Volatility

41.62%
COLL 10-day historical volatility is 41.62%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$631.45M
COLL annual revenue is $631.45 million

Revenue Analysts estimate

$742.61M
COLL annual revenue is currently -14.97% lower than the consensus analysts' forecast

Revenue 1-year change

+11.41%
COLL annual revenue is up +11.41% year-on-year

Revenue Sector rank

75.88%
COLL annual revenue is higher than 75.88% of companies in Healthcare sector

EPS

EPS

$1.86
COLL annual earnings per share is $1.86

EPS Analysts estimate

$6.91
COLL annual earnings per share is currently -73.07% lower than the consensus analysts' forecast

EPS 1-year change

+44.19%
COLL annual earnings per share is up +44.19% year-on-year

EPS Sector rank

91.82%
COLL annual earnings per share is higher than 91.82% of companies in Healthcare sector

Profit

Gross profit

$377.34M
COLL annual gross profit is $377.34 million

Gross margin

59.76%
COLL annual gross profit margin is 59.76%

Operating profit

$166.98M
COLL annual operating income is $166.98 million

Operating margin

26.44%
COLL annual operating profit margin is 26.44%

Net income

$69.19M
COLL annual net profit is $69.19 million

Net margin

10.96%
COLL annual net profit margin is 10.96%

Expenses

Total expenses

$464.47M
COLL annual total expenses is $464.47 million

Operating expenses

$210.36M
COLL annual total operating expenses is $210.36 million

Cost of goods sold

$254.10M
COLL annual cost of goods sold is $254.10 million

Selling, general & administrative expenses

$210.36M
COLL annual SGA is $210.36 million

Depreciation and amortization

$169.16M
COLL annual depreciation & amortization is $169.16 million

Interest expense

$73.97M
COLL annual interest expense is $73.97 million

Income tax

$29.38M
COLL annual income tax is $29.38 million

EBIT & EBITDA

EBIT

$172.54M
COLL annual earnings before interest & taxes is $172.54 million

EBITDA

$341.70M
COLL annual EBITDA is $341.70 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.66B
COLL annual total assets is $1.66 billion

Non current assets

$1.18B
COLL annual long term assets is $1.18 billion

Current assets

$482.26M
COLL annual total current assets is $482.26 million

Cash and cash equivalents

$70.56M
COLL annual cash & cash equivalents is $70.56 million

Accounts receivable

$228.54M
COLL annual accounts receivable is $228.54 million

Inventory

$35.56M
COLL annual inventory is $35.56 million

Liabilities

Total liabilities

$1.43B
COLL annual total liabilities is $1.43 billion

Long term liabilities

$925.24M
COLL annual total long term liabilities is $925.24 million

Current liabilities

$509.51M
COLL annual total current liabilities is $509.51 million

Accounts payable

$3.93M
COLL annual accounts payable is $3.93 million

Debt

Total debt

$859.30M
COLL annual total debt is $859.30 million

Total debt 1-year change

+27.44%
COLL annual total debt is up +27.44% year-on-year

Long term debt

$793.44M
COLL annual long term debt is $793.44 million

Short term debt

$65.85M
COLL annual short term debt is $65.85 million

Equity & Capital

Shareholders equity

$228.84M
COLL annual stockholders equity is $228.84 million

Book value

$228.84M
COLL annual book value is $228.84 million

Retained earnings

-$164.00M
COLL annual retained earnings is -$164.00 million

Working capital

-$27.25M
COLL annual working capital is -$27.25 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$204.98M
COLL annual cash flow from operations is $204.98 million

Cash from operations 1-year change

-25.39%
COLL annual cash flow from operations is down -25.39% year-on-year

Cash from investing

-$287.76M
COLL annual cash flow from investing activities is -$287.76 million

Cash from investing 1-year change

-306.37%
COLL annual cash flow from investing activities is down -306.37% year-on-year

Cash from financing

-$60.60M
COLL annual cash flow from financing activities is -$60.60 million

Cash from financing 1-year change

+56.77%
COLL annual cash flow from financing activities is up +56.77% year-on-year

CAPEX

CAPEX

$1.65M
COLL annual capital expenditures is $1.65 million

CAPEX 1-year change

+258.35%
COLL annual capital expenditures is up +258.35% year-on-year

Free Cash Flow

Free cash flow

$203.33M
COLL annual free cash flow is $203.33 million

Free cash flow 1-year change

-25.87%
COLL annual free cash flow is down -25.87% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

59.76%
COLL annual gross profit margin is 59.76%

Operating margin

26.44%
COLL annual operating profit margin is 26.44%

Net margin

10.96%
COLL annual net profit margin is 10.96%

ROA & ROE

ROA

4.93%
COLL annual return on assets is 4.93%

ROE

32.62%
COLL annual return on equity is 32.62%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

14.40
COLL price to earnings ratio is 14.40

PE ratio Sector rank

25%
COLL price to earnings ratio is higher than 25% of companies in Healthcare sector

PB Ratio

PB ratio

3.69
COLL price to book ratio is 3.69

PB ratio Sector rank

76.33%
COLL price to book ratio is higher than 76.33% of companies in Healthcare sector

PS Ratio

PS ratio

1.34
COLL price to sales ratio is 1.34

PS ratio Sector rank

32.08%
COLL price to sales ratio is higher than 32.08% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.63B
COLL enterprise value is $1.63 billion

Enterprise value Sector rank

79.98%
COLL enterprise value is higher than 79.98% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

4.78
COLL EV/EBITDA is 4.78

EV/EBITDA Sector rank

78.1%
COLL EV/EBITDA is higher than 78.1% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.95
COLL annual current ratio is 0.95

Quick ratio

0.88
COLL annual quick ratio is 0.88

Leverage

Debt to equity

3.73
COLL annual debt to equity ratio is 3.73

Interest coverage ratio

2.33
COLL annual interest coverage ratio is 2.33

Risk & Stability

Piotroski F-Score

5
COLL piotroski f-score is 5

Altman Z-Score

0.92
COLL altman z-score is 0.92

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Buy
Mar 24, 25 HC Wainwright & Co.
Buy
Feb 4, 25 Piper Sandler
Neutral
Jan 10, 25 Needham
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Oct 11, 24 Piper Sandler
Neutral
Sep 5, 24 HC Wainwright & Co.
Buy
Aug 9, 24 Truist Securities
Buy
Aug 9, 24 Piper Sandler
Neutral
Aug 9, 24 Needham
Hold

Institutional Ownership

Similar stocks

AVDL logo
Avadel Pharmaceuticals (AVDL)
VIR logo
Vir Biotechnology (VIR)
GYRE logo
Gyre Therapeutics (GYRE)
SYRE logo
Spyre Therapeutics (SYRE)
NTLA logo
Intellia Therapeutics (NTLA)
MLYS logo
Mineralys Therapeutics (MLYS)
ESTA logo
Establishment Labs Holdings (ESTA)
OCS logo
Oculis Holding AG (OCS)
ZYME logo
Zymeworks (ZYME)
  • What is the ticker symbol for Collegium Pharmaceutical?
  • Does Collegium Pharmaceutical pay dividends?
  • What sector is Collegium Pharmaceutical in?
  • What industry is Collegium Pharmaceutical in?
  • What country is Collegium Pharmaceutical based in?
  • When did Collegium Pharmaceutical go public?
  • Is Collegium Pharmaceutical in the S&P 500?
  • Is Collegium Pharmaceutical in the NASDAQ 100?
  • Is Collegium Pharmaceutical in the Dow Jones?
  • When was Collegium Pharmaceutical's last earnings report?
  • When does Collegium Pharmaceutical report earnings?
  • Should I buy Collegium Pharmaceutical stock now?

What is the ticker symbol for Collegium Pharmaceutical?

The ticker symbol for Collegium Pharmaceutical is NASDAQ:COLL

Does Collegium Pharmaceutical pay dividends?

No, Collegium Pharmaceutical does not pay dividends

What sector is Collegium Pharmaceutical in?

Collegium Pharmaceutical is in the Healthcare sector

What industry is Collegium Pharmaceutical in?

Collegium Pharmaceutical is in the Drug Manufacturers - Specialty & Generic industry

What country is Collegium Pharmaceutical based in?

Collegium Pharmaceutical is headquartered in United States

When did Collegium Pharmaceutical go public?

Collegium Pharmaceutical's initial public offering (IPO) was on May 7, 2015

Is Collegium Pharmaceutical in the S&P 500?

No, Collegium Pharmaceutical is not included in the S&P 500 index

Is Collegium Pharmaceutical in the NASDAQ 100?

No, Collegium Pharmaceutical is not included in the NASDAQ 100 index

Is Collegium Pharmaceutical in the Dow Jones?

No, Collegium Pharmaceutical is not included in the Dow Jones index

When was Collegium Pharmaceutical's last earnings report?

Collegium Pharmaceutical's most recent earnings report was on Feb 27, 2025

When does Collegium Pharmaceutical report earnings?

The next expected earnings date for Collegium Pharmaceutical is May 8, 2025

Should I buy Collegium Pharmaceutical stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page